External beam radiotherapy for carcinoma of the prostate
نویسندگان
چکیده
منابع مشابه
Hypofractionated External-Beam Radiotherapy for Prostate Cancer
There are radiobiological rationales supporting hypofractionated radiotherapy for prostate cancer. The recent advancements in treatment planning and delivery allow sophisticated radiation treatments to take advantage of the differences in radiobiology of prostate cancer and the surrounding normal tissues. The preliminary results from clinical studies indicate that abbreviated fractionation prog...
متن کاملExternal Beam Radiotherapy in Prostate Cancer
For the first time in their history, the 2 medical organizations most responsible for the treatment of prostate cancer in the United States—the American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA)—have issued a joint guideline, a series of 9 major statements on the use of radiation therapy (either adjuvant or salvage) after prostatectomy. The statements ...
متن کاملExternal Beam Radiotherapy in Prostate Cancer
For the first time in their history, the 2 medical organizations most responsible for the treatment of prostate cancer in the United States—the American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA)—have issued a joint guideline, a series of 9 major statements on the use of radiation therapy (either adjuvant or salvage) after prostatectomy. The statements ...
متن کاملDosimetric Characteristics of Transparent Bolus for External Beam Radiotherapy
Introduction: In radiotherapy, the bolus is often used while treating the tumor under the uneven surfaces of the patients for correcting the anatomical irregularities and increasing skin dose. Wet cotton and wet gauze are still used in developing countries, since the use of wet cotton and wet gauze has certain disadvantages, there is a need for transparent bolus which ...
متن کاملDefining a dose-response relationship for prostate external beam radiotherapy.
INTRODUCTION We aimed to quantify a relationship between radiotherapy dose and freedom from biochemical failure (FFBF) in low- and intermediate-risk prostate cancer. To reduce confounding we used data with a standardised end-point, mature follow-up, low competing risk of metastatic failure, conventional fractionation and separate reporting for outcomes with hormonal therapy (HT). METHODS A sy...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer
سال: 1989
ISSN: 0008-543X,1097-0142
DOI: 10.1002/1097-0142(19890615)63:12<2468::aid-cncr2820631218>3.0.co;2-c